Brief: Guerbet announces agreement with Fuji Pharma
31/07/2015 07:01
July 31 (Reuters) - Guerbet SA GRBT.PA :
* Guerbet signs an agreement with Fuji Pharma Co Ltd
4554.T to market its range of contrast media in Japan
* This offering in Japan includes three contrast media
* One for MRI imaging: Magnescope (distributed outside of
Japan under the brand name Dotarem(R) leading contrast agent in
Europe)
* One for X-Ray imaging contrast media: Hexabrix(R) 320
* One for interventional radiology: Lipiodol(R)
Source text for Eikon: ID:nHUG37Cy82
Further company coverage: GRBT.PA
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 698 3920;))